Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Liveris will stay on longer at DowDuPont

by Alexander H. Tullo
May 22, 2017 | A version of this story appeared in Volume 95, Issue 21

Dow Chemical CEO Andrew N. Liveris will stay on for longer than originally anticipated as chairperson of DowDuPont, which is expected to be formed in August through the merger of Dow Chemical and DuPont. He will serve as chairperson through July 1, 2018. He originally was to leave by the middle of this year. However, the deal did not close late last year as originally anticipated. A board has also been named for DowDuPont. It will include 16 directors, eight each from Dow and DuPont. The board will oversee the split, 18 months after the merger closes, of DowDuPont into three separate firms.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.